The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
Open accessAbstract
The single-arm, phase 2 ENESTfreedom trial assessed the potential for treatment-free remission (TFR; i.e., the ability to maintain a molecular response after stopping therapy) following frontline nilotinib treatment. Patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase with MR 4.5 ( BCR-ABL1 ⩽ 0.0032% on the International Scale ( BCR-ABL1 IS )) and ⩾ 2 years of frontline nilotinib therapy were enrolled. Patients with sustained deep molecular response during the 1-year nilotinib consolidation phase were eligible to stop treatment and enter the TFR phase. Patients with loss of major molecular response (MMR; BCR-ABL1 IS ⩽ 0.1%) during the TFR phase reinitiated nilotinib. In total, 215 patients entered the consolidation phase, of whom 190 entered the TFR phase. The median duration of nilotinib before stopping treatment was 43.5 months. At 48 weeks after stopping nilotinib, 98 patients (51.6%; 95% confidence interval, 44.2–58.9%) remained in MMR or better (primary end point). Of the 86 patients who restarted nilotinib in the treatment reinitiation phase after loss of MMR, 98.8% and 88.4%, respectively, regained MMR and MR 4.5 by the data cutoff date. Consistent with prior reports of imatinib-treated patients, musculoskeletal pain-related events were reported in 24.7% of patients in the TFR phase (consolidation phase, 16.3%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-501569 · Cited by 1,987
Self-citationMahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
Bower, H., Björkholm, M., Dickman, P. W., Höglund, M., Lambert, P. C., & Andersson, T. M.-L. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.2866 · Cited by 904
Hochhaus, A., Saglio, G., Hughes, T. P., Larson, R. A., Kim, D.-W., Issaragrisil, S., le Coutre, P. D., Etienne, G., Dorlhiac-Llacer, P. E., Clark, R. E., et al. (2016) · Leukemia · doi:10.1038/leu.2016.5 · Cited by 839
Self-citationRoss, D. M., Branford, S., Seymour, J. F., Schwarer, A. P., Arthur, C., Yeung, D. T., Dang, P., Goyne, J. M., Slader, C., Filshie, R. J., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483750 · Cited by 710
Self-citationRousselot, P., Charbonnier, A., Cony-Makhoul, P., Agape, P., Nicolini, F. E., Varet, B., Gardembas, M., Etienne, G., Réa, D., Roy, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5797 · Cited by 416
Cross, N. C. P., White, H. E., Colomer, D., Ehrencrona, H., Foroni, L., Gottardi, E., Lange, T., Lion, T., Machova Polakova, K., Dulucq, S., et al. (2015) · Leukemia · doi:10.1038/leu.2015.29 · Cited by 336
Self-citationMoving treatment-free remission into mainstream clinical practice in CML
Hughes, T. P., & Ross, D. M. (2016) · Blood · doi:10.1182/blood-2016-01-694265 · Cited by 317
Self-citationImagawa, J., Tanaka, H., Okada, M., Nakamae, H., Hino, M., Murai, K., Ishida, Y., Kumagai, T., Sato, S., Ohashi, K., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00196-9 · Cited by 306
The concept of treatment-free remission in chronic myeloid leukemia
Saußele, S., Richter, J., Hochhaus, A., & Mahon, F.-X. (2016) · Leukemia · doi:10.1038/leu.2016.115 · Cited by 247
Self-citationLee, S.-E., Choi, S. Y., Song, H.-Y., Kim, S.-H., Choi, M.-Y., Park, J. S., Kim, H.-J., Kim, S.-H., Zang, D. Y., Oh, S., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.139899 · Cited by 166
Richter, J., Söderlund, S., Lübking, A., Dreimane, A., Lotfi, K., Markevärn, B., Själander, A., Saußele, S., Olsson‐Strömberg, U., & Stenke, L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.6910 · Cited by 136
Hochhaus, A., Rosti, G., Cross, N. C. P., Steegmann, J. L., le Coutre, P., Ossenkoppele, G. J., Petrov, L., Masszi, T., Hellmann, A., Griškevičius, L., et al. (2015) · Leukemia · doi:10.1038/leu.2015.270 · Cited by 110
Self-citationMeasuring the symptom burden associated with the treatment of chronic myeloid leukemia
Williams, L. A., García-González, A., Ault, P. S., Mendoza, T. R., Sailors, M. L., Williams, J. L., Huang, F., Nazha, A., Kantarjian, H. M., Cleeland, C. S., et al. (2013) · Blood · doi:10.1182/blood-2013-01-477687 · Cited by 109
Jones, D. M., Kamel‐Reid, S., Bahler, D. W., Dong, H. Y., Elenitoba‐Johnson, K. S. J., Press, R. D., Quigley, N. B., Rothberg, P. G., Sabath, D., Viswanatha, D. S., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2009.080095 · Cited by 83
Mahon, F., Richter, J., Guilhot, J., Hjorth‐Hansen, H., de Almeida, A. P., Janssen, J. J. W. M., Mayer, J., Porkka, K., Panayiotidis, P. G., Strömberg, U., et al. (2016) · Blood · doi:10.1182/blood.v128.22.787.787 · Cited by 62
Self-citationMahon, F., Nicolini, F. E., Noël, M., Escoffre‐Barbe, M., Charbonnier, A., Réa, D., Dubruille, V., Varet, B. R., Legros, L., Guerci‐Bresler, A., et al. (2013) · Blood · doi:10.1182/blood.v122.21.654.654 · Cited by 60
Mahon, F., Richter, J., Guilhot, J., Müller, M. C., Dietz, C., Porkka, K., Hjorth‐Hansen, H., Gruber, F., Panagoitidis, P., Ossenkoppele, G. J., et al. (2014) · Blood · doi:10.1182/blood.v124.21.151.151 · Cited by 54
Self-citationRéa, D., Rousselot, P. H., Guilhot, F., Tulliez, M., Nicolini, F. E., Guerci‐Bresler, A., Legros, L., Gardembas, M., Giraudier, S., Guillerm, G., et al. (2012) · Blood · doi:10.1182/blood.v120.21.916.916 · Cited by 40
Rousselot, P. H., Charbonnier, A., Cony‐Makhoul, P., Agapé, P., Nicolini, F. E., Varet, B. R., Gardembas, M., Étienne, G., Réa, D., Roy, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.3858 · Cited by 11
Mahon, F., & Saußele, S. (2016) · Hematologic malignancies · doi:10.1007/978-3-319-33198-0_13 · Cited by 5
Cited by
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547
Self-citationSaussele, S., Richter, J., Guilhot, J., Gruber, F. X., Hjorth-Hansen, H., Almeida, A., Janssen, J. J. W. M., Mayer, J., Koskenvesa, P., Panayiotidis, P., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30192-x · Cited by 618
Self-citationResponse and Resistance to BCR-ABL1-Targeted Therapies
Braun, T. P., Eide, C. A., & Druker, B. J. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.006 · Cited by 483
Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring
Jabbour, E., & Kantarjian, H. (2020) · American Journal of Hematology · doi:10.1002/ajh.25792 · Cited by 410
Ramsey, H. E., Fischer, M. A., Lee, T., Gorska, A. E., Arrate, M. P., Fuller, L., Boyd, K. L., Strickland, S. A., Sensintaffar, J., Hogdal, L. J., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0140 · Cited by 379
Metadata
- Authors
- Hochhaus, A., Masszi, T., Giles, F. J., Radich, J. P., Ross, D. M., Gómez Casares, M. T., Hellmann, A., Stentoft, J., Conneally, E., García-Gutiérrez, V, Gattermann, N., Wiktor-Jedrzejczak, W., le Coutre, P. D., Martino, B., Saussele, S., Menssen, H. D., Deng, W., Krunic, N., Bedoucha, V, & Saglio, G.
- Venue
- Leukemia
- Published
- 2017-02-20
- Volume
- 31
- Issue
- 7
- Pages
- 1525-1531
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2590307110
- Cited by
- 293
- References
- 23
- FWCI
- 26.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.